• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53 肿瘤抑制活性丧失与套细胞淋巴瘤的不良预后相关。

Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma.

机构信息

Department of Pathology, University Hospital Brno, 625 00 Brno, Czech Republic.

出版信息

Int J Oncol. 2010 Mar;36(3):699-706. doi: 10.3892/ijo_00000545.

DOI:10.3892/ijo_00000545
PMID:20126990
Abstract

Mantle cell lymphoma (MCL) is typified by translocation t(11;14)(q13;q32) causing upregulation of cyclin D1 and deregulation of cell cycle. The cyclin D1 activation plays a critical role in MCL pathogenesis but additional oncogenic events, such as aberrations of the ARF/MDM2/p53 pathway are also necessary for progression of the disease. We analyzed the p53 tumor suppressor in tumor tissue of 33 patients with MCL. The p53 status was determined by functional analyses in yeast (FASAY) and by cDNA sequencing. The level of the p53 protein was assessed by immunohistochemistry and immunoblotting. Loss of the p53-specific locus 17p13.3 was detected by FISH. Mutations in the p53 gene were detected in nine samples and they included eight missense mutations and one short deletion causing frame shift and premature stop codon formation in position 169. This mutation was associated with mRNA decay as revealed by sequencing of the p53 gDNA. All eight missense mutations were manifested by accumulation of the p53 protein in nuclei of tumor cells and three of them exhibited loss of the p53-specific locus 17p13.3. The p53 mutations were shown to be a negative prognostic marker in MCL.

摘要

套细胞淋巴瘤(MCL)的特征是易位 t(11;14)(q13;q32),导致 cyclin D1 上调和细胞周期失调。cyclin D1 的激活在 MCL 的发病机制中起着关键作用,但额外的致癌事件,如 ARF/MDM2/p53 通路的异常,也是疾病进展所必需的。我们分析了 33 例 MCL 肿瘤组织中的抑癌基因 p53。通过酵母(FASAY)功能分析和 cDNA 测序确定 p53 状态。通过免疫组化和免疫印迹法评估 p53 蛋白水平。通过 FISH 检测 p53 特异性基因座 17p13.3 的缺失。在九个样本中检测到 p53 基因突变,包括 8 个错义突变和一个短缺失,导致 169 位的移码和提前终止密码子形成。这一突变与 p53 gDNA 测序显示的 mRNA 衰减有关。所有 8 个错义突变都表现为肿瘤细胞核中 p53 蛋白的积累,其中 3 个显示出 p53 特异性基因座 17p13.3 的缺失。p53 突变被证明是 MCL 的一个负预后标志物。

相似文献

1
Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma.p53 肿瘤抑制活性丧失与套细胞淋巴瘤的不良预后相关。
Int J Oncol. 2010 Mar;36(3):699-706. doi: 10.3892/ijo_00000545.
2
Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas.套细胞淋巴瘤和弥漫性大 B 细胞淋巴瘤中 TP53 肿瘤抑制因子的复杂分析。
Oncol Rep. 2017 Oct;38(4):2535-2542. doi: 10.3892/or.2017.5891. Epub 2017 Aug 8.
3
p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32).p53过表达作为伴有t(11;14)(q13;q32)的套细胞淋巴瘤预后不良的标志物
Blood. 1995 Oct 15;86(8):2892-9.
4
p53 and mdm2 in mantle cell lymphoma in leukemic phase.
Haematologica. 2002 Nov;87(11):1141-50.
5
Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.套细胞淋巴瘤变异型里氏综合征:详细的分子细胞遗传学及回溯分析显示,一个前套细胞淋巴瘤克隆在数年间与慢性淋巴细胞白血病平行缓慢演变。
Int J Cancer. 2016 Nov 15;139(10):2252-60. doi: 10.1002/ijc.30263. Epub 2016 Aug 2.
6
A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.一种新的多发性骨髓瘤细胞系MEF-1,存在细胞周期蛋白D1过表达和p53突变。
Cancer. 1999 Apr 15;85(8):1750-7. doi: 10.1002/(sici)1097-0142(19990415)85:8<1750::aid-cncr15>3.0.co;2-5.
7
Characterization of 4 mantle cell lymphoma cell lines.4种套细胞淋巴瘤细胞系的特征分析
Arch Pathol Lab Med. 2003 Apr;127(4):424-31. doi: 10.5858/2003-127-0424-COMCLC.
8
[Research advance of p53 gene in mantle cell lymphoma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Jun;19(3):835-8.
9
No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo.体内套细胞淋巴瘤无细胞周期失调的证据。
Leuk Lymphoma. 2015 Jul;56(7):2134-40. doi: 10.3109/10428194.2014.975700. Epub 2014 Nov 14.
10
Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma.p53、Sox11 和 Pax5 共表达在套细胞淋巴瘤中的预后意义。
Sci Rep. 2021 Jun 7;11(1):11896. doi: 10.1038/s41598-021-91433-7.

引用本文的文献

1
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy.从血液系统恶性肿瘤中p53的调控到去调控:对诊断、预后和治疗的影响
Biomark Res. 2024 Nov 14;12(1):137. doi: 10.1186/s40364-024-00676-9.
2
Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).套细胞淋巴瘤高危患者(高危 MIPI-c 或高 p53 表达)的临床结局。
Leukemia. 2023 Sep;37(9):1887-1894. doi: 10.1038/s41375-023-01977-y. Epub 2023 Jul 26.
3
Prognostic value and computer image analysis of p53 in mantle cell lymphoma.
p53 在套细胞淋巴瘤中的预后价值及计算机图像分析。
Ann Hematol. 2022 Oct;101(10):2271-2279. doi: 10.1007/s00277-022-04922-8. Epub 2022 Aug 3.
4
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study.ZUMA-2 研究中复发/难治性套细胞淋巴瘤患者(包括高危亚组)接受 KTE-X19 的 3 年随访结果。
J Clin Oncol. 2023 Jan 20;41(3):555-567. doi: 10.1200/JCO.21.02370. Epub 2022 Jun 4.
5
Insuline-Like Growth Factor-2 (IGF2) and Hepatocyte Growth Factor (HGF) Promote Lymphomagenesis in p53-null Mice in Tissue-specific and Estrogen-signaling Dependent Manners.胰岛素样生长因子-2(IGF2)和肝细胞生长因子(HGF)以组织特异性和雌激素信号依赖的方式促进p53基因缺失小鼠的淋巴瘤发生。
J Cancer. 2021 Aug 21;12(20):6021-6030. doi: 10.7150/jca.60120. eCollection 2021.
6
Progress in molecular feature of smoldering mantle cell lymphoma.惰性套细胞淋巴瘤分子特征的研究进展
Exp Hematol Oncol. 2021 Jul 13;10(1):41. doi: 10.1186/s40164-021-00232-3.
7
[Efficacy and prognostic analysis of frontline Bortezomib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone regimens (VR-CAP) for patients with mantle cell lymphoma].硼替佐米、利妥昔单抗、环磷酰胺、多柔比星和泼尼松一线方案(VR-CAP)治疗套细胞淋巴瘤患者的疗效及预后分析
Zhonghua Xue Ye Xue Za Zhi. 2021 May 14;42(5):415-419. doi: 10.3760/cma.j.issn.0253-2727.2021.05.011.
8
Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma.p53、Sox11 和 Pax5 共表达在套细胞淋巴瘤中的预后意义。
Sci Rep. 2021 Jun 7;11(1):11896. doi: 10.1038/s41598-021-91433-7.
9
High-Risk Mantle Cell Lymphoma in the Era of Novel Agents.新型药物时代的高危套细胞淋巴瘤。
Curr Hematol Malig Rep. 2021 Feb;16(1):8-18. doi: 10.1007/s11899-021-00605-9. Epub 2021 Jan 28.
10
p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma.p53 与高危相关,并可明确套细胞淋巴瘤中的 TP53 错义突变。
Br J Haematol. 2020 Dec;191(5):796-805. doi: 10.1111/bjh.17023. Epub 2020 Aug 4.